Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Wickes Group (WIX) by Harvey Jones in The Motley Fool
- Neutral Burberry Group (BRBY) by UBS
- Watch Johnson Matthey (JMAT) by Harvey Jones in The Motley Fool
- Hold Direct Line Insurance Group (DLG) by Berenberg
- Buy National Grid (NG.) by Simon Watkins in The Motley Fool
- Buy National Grid (NG.) by Bank of America
- Hold Currys (CURY) by Deutsche Bank
- Buy Great Portland Estates (GPE) by Goldman Sachs
- Buy Tate & Lyle (TATE) by Berenberg
- Sector Perform Ceres Power Holdings (CWR) by RBC Capital
- Avoid Lloyds Banking Group (LLOY) by Royston Wild in The Motley Fool
- Buy Persimmon (PSN) by Citi
- Outperform Ashtead Group (AHT) by RBC Capital
- Overweight easyJet (EZJ) by Barclays
- Neutral Oxford Biomedica (OXB) by JP Morgan
- Overweight Hikma Pharmaceuticals (HIK) by JP Morgan
- Buy easyJet (EZJ) by UBS
- Speculative Buy Spirent Communications (SPT) by Canaccord Genuity
- Buy Volution Group (FAN) by Berenberg
- Buy PensionBee Group (PBEE) by Canaccord Genuity
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,183 open tips for AstraZeneca (AZN)
| Latest Bid : 10,764.00p | Latest Ask : 10,768.00p |
| High Today : 10,804.00p | Low Today : 10,562.00p |
| This Years High : 13,276.00p | This Years Low : 9,501.00p |
| Volume : 1,294,408 | MKT Cap : £166904M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2024-11-20 05:57:00 20/11/2024 | 6.70% |
| Neutral | UBS | Premium Only | 2024-11-20 04:48:00 20/11/2024 | – |
| Hold | DZ Bank | Premium Only | 2024-11-13 13:33:00 13/11/2024 | 6.20% |
| Buy | Goldman Sachs | Premium Only | 2024-11-13 07:20:00 13/11/2024 | 5.14% |
| Buy | Ben McPoland | Premium Only | 2024-11-12 14:20:00 12/11/2024 | 8.50% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 10,764.00p | Latest Ask : 10,768.00p |
| High Today : 10,804.00p | Low Today : 10,562.00p |
| This Years High : 13,276.00p | This Years Low : 9,501.00p |
| Volume : 1,294,408 | MKT Cap : £166904M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2024-11-20 05:57:00 20/11/2024 | 6.70% |
| Neutral | UBS | Premium Only | 2024-11-20 04:48:00 20/11/2024 | – |
| Hold | DZ Bank | Premium Only | 2024-11-13 13:33:00 13/11/2024 | 6.20% |
| Buy | Goldman Sachs | Premium Only | 2024-11-13 07:20:00 13/11/2024 | 5.14% |
| Buy | Ben McPoland | Premium Only | 2024-11-12 14:20:00 12/11/2024 | 8.50% |